357 Results (Page 11 of 15)
Vietnam Markets Research Reports
Vietnam Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Vietnam Dermatology drugs market will reach a value of $xx Mn from $85 Mn in 2022, growing at a CAGR of xx% during 2022-30. The market is primarily dominated by local players such as Traphaco, Pymepharco, and Imexpharm. The market is driven by the prevalence of dermatology conditions, awareness about dermatological health, and increasing healthcare spending. The dermatology drug market in Vietnam is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Vietnam Coronary Stents Market Analysis
Vietnam Coronary Stents Market is expected to witness growth from $57 Mn in 2022 to $83 Mn in 2030 with a CAGR of 4.98% for the forecasted year 2022-30. A growing number of foreign patients seeking reasonably priced medical treatments, such as coronary stenting, are choosing Vietnam as their destination of choice for medical tourism. The market for coronary stents is anticipated to rise as a result of more medical institutions increasing their product offerings to meet the needs of this market. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Vinamed, VietMedical, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
Vietnam Acne Therapeutics Market Analysis
This report presents a strategic analysis of the Vietnam Acne Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Acne Therapeutics Market, offering unmatched value, accuracy, and expert insights.
Vietnam ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
This report presents a strategic analysis of the Vietnam ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market, offering unmatched value, accuracy, and expert insights.
Vietnam 3D Imaging Market Analysis
Vietnam's 3D imaging market is projected to grow from $0.15 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by the growing need for modern medical technology, greater emphasis on enhancing healthcare services, and rising investments in cutting-edge medical technology. The market is segmented by product, application, end-user & portability. Some of the major players include GE Healthcare, Siemens Healthineers & FPT Corporation
Vietnam Dermatological Therapeutics Market Analysis
Vietnam Dermatological Therapeutics Market is at around $0.21 Bn in 2023 and is projected to reach $0.37 Bn in 2030, exhibiting a CAGR of 8.83% during the forecast period. Advances in technology, the prevalence of skin disorders, and increased awareness of skin health are driving the expansion of the market. The market is dominated by key players like Almirall SA, Pfizer Inc., GlaxoSmithKline Plc (GSK), AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.
Vietnam Alopecia (Hair Loss) Therapeutics Market Analysis
The Vietnam Alopecia (Hair Loss) Therapeutics Market was valued at US $41 Mn in 2022, and is predicted to grow at (CAGR) of 7.73% from 2023 to 2030, to US $74 Mn by 2030. The main drivers advancing this industry are primarily the significant rise in the prevalence of alopecia (hair loss), demographic shifts, lifestyle modifications, and others. The industry is primarily dominated by players such as Sun Pharmaceuticals, Johnson & Johnson, Cirrus, Cipla, Lexington, and Merck, among others
Vietnam Allergy Therapeutics Market Analysis
Vietnam allergy therapeutics market was valued at $116 Mn in 2022 and is estimated to reach $194 Mn in 2030, exhibiting a CAGR of 6.63% during the forecast period. The demand for allergy treatment drugs is expanding due to the increased prevalence of allergic disorders and associated health problems. The top pharmaceutical companies that are currently operating in the market are GlaxoSmithKline, Novartis, Sanofi, AstraZeneca, Bayer, Pfizer, Abbott, Teva Pharmaceutical, DHG Pharma and Boston Pharmaceuticals.
Vietnam Alcohol Addiction Therapeutics Market Analysis
The Vietnam Alcohol Addiction Therapeutics Market is valued at around $4 Mn in 2022 and is projected to reach $6 Mn by 2030, exhibiting a CAGR of 6.53% during the forecast period. The market drivers in the Vietnam Alcohol Addiction Therapeutic Market include factors like rising harmful alcohol use among the 18–29 age group, increased recognition of alcohol addiction as a treatable mental health issue, and growing demand for therapeutic innovation in addiction therapy. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Vietnam are Abbott, Pfizer, AstraZeneca, Roche, Lundbeck, Traphaco, Hau Giang Pharmaceuticals, Bidipharm Pharmaceuticals, Stada Vietnam, Mylan Laboratories, etc., among others.
Vietnam Cardiovascular Drugs Market Analysis
Vietnam Cardiovascular Drug Market is at around $0.7 Bn in 2022 and is projected to reach $0.95 Bn in 2030, exhibiting a CAGR of 4.03% during the forecast period. The market is growing due to an increase in cardiovascular burden, rising awareness for healthcare, and improved healthcare infrastructure. The market is dominated by key players like Ha Tay Pharmaceutical, OPC Pharmaceutical, ImexPharm, Binh Dinh Pharmaceutical, Mylan and Teva, Sun Pharmaceutical, F. Hoffman-La Roche, Pfizer Inc., Astra Zeneca, Sanofi, Novartis, and GSK.
Vietnam Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The Vietnam Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $17 Mn in 2022, and is predicted to grow at (CAGR) of 8.03% from 2023 to 2030, to US $31 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic leukemia cases, the adoption of novel therapies, increased government initiatives, and other factors. The industry is primarily dominated by players such as Hau Giang, Vietnam Pharma, Pfizer, Novartis, among others
Vietnam Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The Vietnam Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $6 Mn in 2022 and is predicted to grow at a CAGR of 6.03% from 2023 to 2030, to US $9 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of autosomal dominant polycystic kidney disease, government initiatives, increased awareness, and other factors. The industry is primarily dominated by players such as Otsuka, AceLink, Palladio, Reata, Xortx, Regulus, Exelixis, Sanofi and other players
Vietnam Age-Related Macular Degeneration Therapeutics Market Analysis
The Vietnam Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $54 Mn in 2022 and is predicted to grow at a CAGR of 9.13% from 2023 to 2030, to US $109 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, improved healthcare infrastructure, and other factors. The industry is primarily dominated by players such as Regeneron Pharmaceuticals, Novartis, Bayer, Roche, and Genetech, among others
Vietnam Addiction Therapeutics Market Analysis
Vietnam addiction therapeutics market was valued at $51 Mn in 2022 and is estimated to reach $88 Mn in 2030, exhibiting a CAGR of 7.13% during the forecast period. The growth of programs aimed at increasing drug knowledge and avoiding substance usage is one of the main drivers of the addiction therapeutics market. Dominant key players operating in the market include Indivior, Alkermes, Reckitt Benckiser, Otsuka Pharmaceutical Co., Pfizer, Mallinckrodt, Purdue Pharma L.P., GlaxoSmithKline, Teva Pharmaceutical and Novartis
Vietnam Adult Malignant Glioma Therapeutics Market Analysis
The Vietnam Adult Glioma Therapeutics Market is valued at around $11 Mn in 2022 and is projected to reach $22 Mn by 2030, exhibiting a CAGR of 9.13% during the forecast period. Vietnam's pharmaceutical sector heavily relies on imported drugs, particularly specialized ones like glioma treatments, with local companies focusing on generic versions for the price-sensitive market, while the country lacks regional participants, creating opportunities for new drugs to capture market share in response to the growing demand for effective glioma treatments. Key players in the Vietnam Adult Malignant Glioma Therapeutics Market include companies like Roche, Novartis, Merck & Co., Pfizer, Bristol-Myers Squibb, AbbVie, Stada Vietnam, Mekophar, Boston-Vietnam Pharma, Novogene, etc. among others.
Vietnam Sleep Disorders Market Analysis
This report presents a strategic analysis of the Vietnam Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Sleep Disorders Market, offering unmatched value, accuracy, and expert insights.
Vietnam Neurology Devices Market Analysis
Vietnam Neurology Device Market is expected to witness growth from $63 Mn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-30. The Neurology devices market in Vietnam is being driven by the increase in neurological disorders like epilepsy, Parkinson's disease, and Alzheimer's disease. The market is segmented by product type and by the end user. Some key players in this market include Medtronic, Johnson and Johnson, GE Healthcare, Stryker, Abbott laboratories and Philips Healthcare.
Vietnam Healthcare Claims Management Market Analysis
Vietnam's healthcare claims management market is projected to grow from $133.5 Mn in 2022 to $728.57 Mn by 2030, registering a CAGR of 23.63% during the forecast period of 2022-30. The main factors driving the growth would be government support, increasing awareness of healthcare insurance, and increasing healthcare spending. The market is segmented by component, type, delivery mode, and by end-user. Some of the major players include FPT Corporation, INSO, Cigna, Allianz, and WellPoint.
Vietnam ECG Equipments Market Analysis
Vietnam ECG Equipment Market is expected to witness growth from $45 Mn in 2022 to $80 Mn in 2030 with a CAGR of 7.53% for the forecasted year 2022-30. The frequency of coronary artery disease is rising in Vietnam, where coronary heart disease and stroke are the primary causes of death. The demand for ECG equipment is anticipated to increase due to the increasing occurrence of CVDs. The market is segmented by product type and by the end user. Some key players in this market include CPT SUTURES, J&V Medical Instrument JSC, Johnson & Johnson, Philipps Healthcare, Medtronic and Dexcom.
Vietnam Depression Therapeutics Market Analysis
Vietnam's depression therapeutics market is expected to witness growth from $51 Mn in 2022 to $77 Mn in 2030 with a CAGR of 5.43% for the forecasted year 2022-30. The rising awareness about depression and the easy availability of depression treatments in Vietnam are driving the growth of the market. The Vietnam depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Pymepharco, Lam Dong Pharmaceutical, and Allergan are the major players in the Vietnam depression therapeutics market.
Vietnam Contraceptive Devices Market Analysis
Vietnam Contraceptive Devices Market is expected to witness growth from $65 Mn in 2022 to $121 Mn in 2030 with a CAGR of 8.23% for the forecasted year 2022-30. Over 98 million people currently live in Vietnam, and it is anticipated that this number will rise over the next few years. As more people try to plan their families, this means that the demand for contraceptive devices will rise. The market is segmented by type and by gender. Some key players in this market include USM Healthcare, Omron Healthcare Vietnam, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Vietnam Over The Counter (OTC) Pharmaceuticals Market Analysis
Vietnam's over-the-counter (OTC) pharmaceuticals market size was valued at $687.5 Mn in 2022 and is estimated to expand at a CAGR of 5.33% from 2022 to 2030 and will reach $1041.6 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
Vietnam Bioinformatics Market Analysis
Vietnam's Bioinformatics market is projected to grow from $ 76.75 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be advancements in technology, the growing healthcare sector, and investment in research and development. The market is segmented by technology and by application. Some of the major players include LOBI Vietnam (VNM), Agilent Technologies, IBM Life Sciences, and ThermoFisher Scientific.
Vietnam Oncology Clinical Trials Market Analysis
Vietnam's oncology clinical trials market is projected to grow from $63.3 Mn in 2022 to $98.8 Mn by 2030, registering a CAGR of 5.73% during the forecast period of 2022-30. The market will be driven by the big and diversified patient population available for clinical trials and a well-established clinical trial regulatory structure. The market is segmented by phase, by study design & by indication. Some of the major players include AstraZeneca PLC, Novartis AG & Hau Giang Pharmaceutical Joint Stock Company.
Vietnam Digital Health Market Analysis
Vietnam's Digital Health market is projected to grow from $xxBn in 2022 to $xxBn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by government support and the increasing use of technology in healthcare. The market is segmented by solution, by deployment & by end-use. Some of the major players include Jio Health, eDoctor & Thuocsi.